VF
Virtu Financial Portfolio holdings
AUM
$1.96B
1-Year Return
26.08%
This Quarter Return
+11.49%
1 Year Return
+26.08%
3 Year Return
+87.7%
5 Year Return
+194.31%
10 Year Return
–
AUM
$1.41B
AUM Growth
+$485M
(+52%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
32.88%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
2,402
New
1,007
Increased
232
Reduced
295
Closed
857
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$213M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$99.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$73.9M |
| 4 |
Cleveland-Cliffs
CLF
|
$24.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$16M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$24.5M |
| 2 |
BTAQU
Burgundy Technology Acquisition Corporation Unit
BTAQU
|
$11.5M |
| 3 |
FTIVU
FinTech Acquisition Corp. IV Unit
FTIVU
|
$10.3M |
| 4 |
Direxion Daily Technology Bull 3x Shares
TECL
|
$8.19M |
| 5 |
DocuSign
DOCU
|
$7.25M |
Sector Composition
| 1 | Financials | 12.42% |
| 2 | Technology | 9.73% |
| 3 | Consumer Discretionary | 8.07% |
| 4 | Healthcare | 7.96% |
| 5 | Communication Services | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
JFrog
FROG
$5.84B
| $859K | 0.06% |
+19,354
| New | +$859K |
|
302
Royal Caribbean
RCL
$95.7B
| $854K | 0.06% |
+9,977
| New | +$854K |
|
303
Stanley Black & Decker
SWK
$12.1B
| $852K | 0.06% |
+4,266
| New | +$852K |
|
304
LiveOne
LVO
$51.2M
| $849K | 0.06% |
+195,667
| New | +$849K |
|
305
Zimmer Biomet
ZBH
$20.9B
| $843K | 0.06% |
+5,427
| New | +$843K |
|
|
SVACU
306
DELISTED
Starboard Value Acquisition Corp. Unit
SVACU
| $840K | 0.06% |
+82,473
| New | +$840K |
|
307
Eaton
ETN
$136B
| $839K | 0.06% |
+6,070
| New | +$839K |
|
308
Traws Pharma
TRAW
$12.6M
| $836K | 0.06% |
2,232
+939
| +73% | +$352K |
|
309
Aterian
ATER
$9.76M
| $835K | 0.06% |
+2,358
| New | +$835K |
|
310
LendingTree
TREE
$978M
| $833K | 0.06% |
3,909
+2,691
| +221% | +$573K |
|
|
DRE
311
DELISTED
Duke Realty Corp.
DRE
| $824K | 0.06% |
+19,640
| New | +$824K |
|
312
IBM
IBM
$232B
| $823K | 0.06% |
6,457
+3,388
| +110% | +$432K |
|
313
ING
ING
$71B
| $823K | 0.06% |
67,303
+43,957
| +188% | +$538K |
|
314
CME Group
CME
$94.4B
| $818K | 0.06% |
+4,007
| New | +$818K |
|
315
Insulet
PODD
$24.5B
| $817K | 0.06% |
3,132
+1,535
| +96% | +$400K |
|
316
Editas Medicine
EDIT
$248M
| $807K | 0.06% |
19,203
+244
| +1% | +$10.3K |
|
317
UDR
UDR
$13B
| $801K | 0.06% |
+18,272
| New | +$801K |
|
318
Ambev
ABEV
$34.8B
| $800K | 0.06% |
291,790
+85,927
| +42% | +$236K |
|
319
Carisma Therapeutics
CARM
$16.8M
| $798K | 0.06% |
15,353
+1,853
| +14% | +$96.3K |
|
320
Vail Resorts
MTN
$5.87B
| $792K | 0.06% |
+2,715
| New | +$792K |
|
321
Sarepta Therapeutics
SRPT
$1.96B
| $789K | 0.06% |
10,586
+7,142
| +207% | +$532K |
|
322
Labcorp
LH
$23.2B
| $787K | 0.06% |
+3,591
| New | +$787K |
|
323
Danaher
DHR
$143B
| $779K | 0.06% |
3,904
-17,421
| -82% | -$3.48M |
|
|
ATAC.U
324
DELISTED
Altimar Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
ATAC.U
| $775K | 0.05% |
75,795
-59,857
| -44% | -$612K |
|
325
Ouster
OUST
$1.59B
| $771K | 0.05% |
+9,068
| New | +$771K |
|